Erratum to: Neurotherapeutics
DOI 10.1007/s13311-016-0508-5
The phrase “and family members” should be deleted from the second sentence in Paragraph 1 of Discussion. The correct sentence is:
“Considering past ALS treatment trials, this study is unique for several reasons. Firstly, it was driven by reports from patients who, having been treated for one condition (PBA), reported unexpected benefit upon seemingly unrelated symptoms.”
The sentence starting on line 11, Paragraph 2 of Discussion should read:
Just under half (49%) of the subjects in this study improved by one or more points in the ALSFRS-R bulbar domain with DMQ treatment relative to their response on placebo (26%).
Author information
Authors and Affiliations
Corresponding author
Additional information
The online version of the original article can be found at http://dx.doi.org/10.1007/s13311-016-0508-5.
Rights and permissions
About this article
Cite this article
Smith, R., Pioro, E., Myers, K. et al. Erratum to: Enhanced Bulbar Function in Amyotrophic Lateral Sclerosis: The Nuedexta Treatment Trial. Neurotherapeutics 14, 830 (2017). https://doi.org/10.1007/s13311-017-0517-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13311-017-0517-z